Vol 68 No 04

In this month's Practice Matters column, James D. Keller, MD, MHSA; and Brian K. Iriye, MD, explore the world of value-based care and how it can benefit your practice.

A literature review found that although hormonal therapy with estrogen is the first-line therapy for bothersome vasomotor symptoms (VMS) and genitourinary syndrome of menopause (GSM) symptoms, nonhormonal medications such as paroxetine and venlafaxine can also be effective for VMS.

Pain mechanisms are multifactorial, complex, and still poorly understood.

Research shows social determinants of health arena.

Learn how and when to counsel your patients.

In honor of World Health Day on April 7, our President and CEO, Mike Hennessy Jr, reflects on the founding of the World Health Organization in his monthly publisher's note.

For pregnant women at high risk of preeclampsia, aspirin discontinuation at 24 to 28 weeks’ gestation was comparable to aspirin continuation for preventing preterm preeclampsia, according to recent clinical trial data.

A recent study highlights barriers to pregnancy prevention for women without permanent housing.

Five water-based personal lubricants were found effective, safe, and well tolerated for the relief of discomfort from vaginal dryness, according to a recently published study.

A look at vaginal laser surgery for overactive bladder syndrome.

A single oral dose of azithromycin in women in labor planning vaginal delivery significantly reduced the risk of maternal death and sepsis, according to study results presented at the SMFM 43rd Annual Pregnancy Meeting.